von Bergmann K - Search Results

1

Efficacy and safety of ezetimibe 40 mg vs. ezetimibe 10 mg in the treatment of patients with homozygous sitosterolaemia.

Musliner T, Cselovszky D, Sirah W, McCrary Sisk C, Sapre A, Salen G, Lütjohann D, von Bergmann K. Musliner T, et al. Among authors: von bergmann k. Int J Clin Pract. 2008 Jul;62(7):995-1000. doi: 10.1111/j.1742-1241.2008.01786.x. Epub 2008 May 14. Int J Clin Pract. 2008. PMID: 18484971 Clinical Trial.

2

Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study.

Lütjohann D, von Bergmann K, Sirah W, Macdonell G, Johnson-Levonas AO, Shah A, Lin J, Sapre A, Musliner T. Lütjohann D, et al. Among authors: von bergmann k. Int J Clin Pract. 2008 Oct;62(10):1499-510. doi: 10.1111/j.1742-1241.2008.01841.x. Int J Clin Pract. 2008. PMID: 18822021 Clinical Trial.

3

Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.

Sudhop T, Reber M, Tribble D, Sapre A, Taggart W, Gibbons P, Musliner T, von Bergmann K, Lütjohann D. Sudhop T, et al. Among authors: von bergmann k. J Lipid Res. 2009 Oct;50(10):2117-23. doi: 10.1194/jlr.P900004-JLR200. Epub 2009 Apr 20. J Lipid Res. 2009. PMID: 19380898 Free PMC article. Clinical Trial.

4

Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia.

Salen G, von Bergmann K, Lütjohann D, Kwiterovich P, Kane J, Patel SB, Musliner T, Stein P, Musser B; Multicenter Sitosterolemia Study Group. Salen G, et al. Among authors: von bergmann k. Circulation. 2004 Mar 2;109(8):966-71. doi: 10.1161/01.CIR.0000116766.31036.03. Epub 2004 Feb 9. Circulation. 2004. PMID: 14769702 Free PMC article. Clinical Trial.

5

Phytosterolaemia: diagnosis, characterization and therapeutical approaches.

Lütjohann D, von Bergmann K. Lütjohann D, et al. Among authors: von bergmann k. Ann Med. 1997 Jun;29(3):181-4. doi: 10.3109/07853899708999333. Ann Med. 1997. PMID: 9240621 Free article. Review.

6

24S-hydroxycholesterol: a marker of brain cholesterol metabolism.

Lütjohann D, von Bergmann K. Lütjohann D, et al. Among authors: von bergmann k. Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S102-6. doi: 10.1055/s-2003-43053. Pharmacopsychiatry. 2003. PMID: 14574622

7

The lipid-lowering effect of ezetimibe in pure vegetarians.

Clarenbach JJ, Reber M, Lütjohann D, von Bergmann K, Sudhop T. Clarenbach JJ, et al. Among authors: von bergmann k. J Lipid Res. 2006 Dec;47(12):2820-4. doi: 10.1194/jlr.P600009-JLR200. Epub 2006 Sep 11. J Lipid Res. 2006. PMID: 16966491 Free article. Clinical Trial.

8

Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine.

Thuluva SC, Igel M, Giesa U, Lütjohann D, Sudhop T, von Bergmann K. Thuluva SC, et al. Among authors: von bergmann k. Int J Clin Pharmacol Ther. 2005 Jul;43(7):305-10. doi: 10.5414/cpp43305. Int J Clin Pharmacol Ther. 2005. PMID: 16035372 Clinical Trial.

9

Degradation of 24S-hydroxycholesterol in men is not regulated by CYP7A1.

Knabe C, Sudhop T, von Bergmann K, Lütjohann D. Knabe C, et al. Among authors: von bergmann k. Int J Clin Pharmacol Ther. 2007 Nov;45(11):577-82. doi: 10.5414/cpp45577. Int J Clin Pharmacol Ther. 2007. PMID: 18077921 Clinical Trial.

10

Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment.

Lütjohann D, Björkhem I, Beil UF, von Bergmann K. Lütjohann D, et al. Among authors: von bergmann k. J Lipid Res. 1995 Aug;36(8):1763-73. J Lipid Res. 1995. PMID: 7595097 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters